Evaluation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ELA026 in Single and Multiple Doses in Healthy Volunteers
Clinical trial NCT05556863 · COMPLETED
Trial details
- NCT number
- NCT05556863
- Sponsor
- Electra Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-18
- Primary completion
- 2023-11-20
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.